"Refine drugs, Benefit mankind" is the core of corporate culture of Hanjiang pharmaceutical. In the face of illness, Hanjiang people can deeply feel the helplessness of poor patients, and relieving the suffering of patients has always been the unchanging initial intention of Hanjiang people. We want to provide charity and public welfare to more poor areas, to focus on and help the disadvantaged people suffering from poverty and diseases,and hope that they all have an equal starting point and a good future.Therefore, Hanjiang pharmaceutical decided to provide free “Albendazole oral emulsion”, the national patent protected drugs for the treatment of Hydatid disease.
► The contents：
Shaanxi Hanjiang Pharmaceutical Group “Albendazole Oral Emulsion” free aid activity.
Aid region：The residents of Ningxia Hui Autonomous Region of China (Phase 1)
Aid date：August 1, 2018 - October 31, 2018
Aid drugs：Albendazole oral emulsion of RMB 1 million yuan
Application requirements：Click here to learn
► What is Hydatid disease(Echinococcosis)?
Hydatid disease(Echinococcosis) is aparasitic zoonosis. The parasitism of alveolar hydatid in echinococcosis multilocularis is called alveolar echinococcosis, which is not easy to be found, but can seriously threaten the health of patients and even lead to death. Hydatid disease is also known as"worm cancer", mainly outbreaks in western China. According to statistics, the prevalence rate in Tibet, the border area of Tibet and Sichuan,and Qinghai province is 2.76%, 2.33% and 1.91% respectively. The population at risk is about 66 million, resulting in a direct economic losses of RMB 3 billion yuan per year.
► How to treat effectively?
"Albendazole oral emulsion" is a national new drug for the treatment of hydatid disease, which was put on the market by Shaanxi Hanjiang Pharmaceutical Group co., Ltd. It is a national patent protected drug with the approval number: H20050961. The drug was developed by Shaanxi Hanjiang Pharmaceutical Group co., Ltd. Chinese Center for Disease Control and Prevention (CDC), Xinjiang Uygur Autonomous Region Center for Disease Controland Prevention, Hydatid disease Prevention Institute of Ministry of Health. "Albendazole oral emulsion" is produced by Shaanxi Hanwang Pharmaceutical Co., Ltd. an authorized holding company of Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. and Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. owns the intellectual property rights of the drug.
"Albendazole oral emulsion" has gained positively recognition by the majority of patients for its good therapeutic effect since its launch. At present, the drug has been recommended by the Ministry of Health as the first selected drug for the treatment of hydatid disease. After more than ten years of clinical application,quality effect is remarkable. The cure rate is up to 95.5%. Compared with albendazole tablets and albendazole capsules, the prevention rate is increasedby 30-40%. The current sales area coverage: Xinjiang Uygur Autonomous Region,Tibet Autonomous Region, Qinghai Province, Gansu Province, Inner Mongolia Autonomous Region, Ningxia Hui Autonomous Region, Sichuan Province and other regions.
Over the years, with ahigh sense of social responsibility, Hanjiang pharmaceutical has been caring for the health of patients in poverty-stricken areas, caring for vulnerable groups, and actively participating in public welfare. On the path of public service, we see persistence from patients and their desire for health. In the future, Hanjiang pharmaceutical will continue to contribute efforts to public service, share our love, help poor patients to improve their health. A point ofheat and a beam of light, the positive energy gathered will be transmitted to more people in need.
Charity and public welfare, we have been on the road...